Status:
ACTIVE_NOT_RECRUITING
Trial of Modifications to Radical Prostatectomy
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Prostate Cancer
Eligibility:
MALE
21+ years
Phase:
PHASE3
Brief Summary
This trial will evaluate whether the following aspect of surgical technique influence outcome: Lymph node dissection. In some patients, scans taken before surgery show that a lymph node has cancer. Su...
Eligibility Criteria
Inclusion
- Patients do not have to be eligible for both modifications to be included in the study.
- Lymphadenectomy vs no lymphadenectomy:
- Patients 21 years or older scheduled for radical prostatectomy for treatment of prostate cancer with one of the consenting surgeons at MSKCC
- Hemostatic agent vs. no hemostatic agent
- Patients 21 years or older scheduled for minimally invasive radical prostatectomy for the treatment of prostate cancer with one of the consenting surgeons at MSKC
Exclusion
- Lymphadenectomy vs no lymphadenectomy
- Presence of positive/suspicious pelvic nodes on MRI, CT or PSMA scan (positive/suspicious defined as a pelvic node \>15mm in short axis on CT or MRI, a PSMA avid node, or a node with abnormal morphology such as roundness or irregularity or loss of fatty hilum)
- Any prior pelvic radiation therapy used to treat prostate cancer
- Hemostatic agent vs. no hemostatic agent
- No additional exclusion criteria
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2026
Estimated Enrollment :
3204 Patients enrolled
Trial Details
Trial ID
NCT01407263
Start Date
July 1 2011
End Date
July 1 2026
Last Update
August 14 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center at Basking Ridge
Basking Ridge, New Jersey, United States, 07920
2
Memorial Sloan Kettering Bergen (Consent Only)
Montvale, New Jersey, United States, 07645
3
Memorial Sloan Kettering Westchester
Harrison, New York, United States, 10604
4
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065